KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Twist Bioscience (TWST) EBT Margin (2018 - 2025)

Historic EBT Margin for Twist Bioscience (TWST) over the last 8 years, with Q4 2025 value amounting to 29.18%.

  • Twist Bioscience's EBT Margin rose 63300.0% to 29.18% in Q4 2025 from the same period last year, while for Dec 2025 it was 19.33%, marking a year-over-year increase of 402600.0%. This contributed to the annual value of 20.43% for FY2025, which is 460800.0% up from last year.
  • As of Q4 2025, Twist Bioscience's EBT Margin stood at 29.18%, which was up 63300.0% from 27.15% recorded in Q3 2025.
  • In the past 5 years, Twist Bioscience's EBT Margin registered a high of 21.43% during Q2 2025, and its lowest value of 133.2% during Q4 2021.
  • In the last 5 years, Twist Bioscience's EBT Margin had a median value of 82.83% in 2022 and averaged 75.88%.
  • Its EBT Margin has fluctuated over the past 5 years, first crashed by -336000bps in 2021, then surged by 1262300bps in 2025.
  • Twist Bioscience's EBT Margin (Quarter) stood at 133.2% in 2021, then surged by 42bps to 76.96% in 2022, then grew by 22bps to 59.98% in 2023, then soared by 41bps to 35.5% in 2024, then grew by 18bps to 29.18% in 2025.
  • Its EBT Margin was 29.18% in Q4 2025, compared to 27.15% in Q3 2025 and 21.43% in Q2 2025.